Literature DB >> 21488122

Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction.

Chao Yuan1, Justin Kosewick, Xiang He, Marta Kozak, Sihe Wang.   

Abstract

Vitamin D plays important roles in bone health and a variety of other pathophysiological conditions. 1α,25-Dihydroxyvitamin D is the active form of vitamin D. Quantification of serum 1α,25-dihydroxyvitamin D is useful for evaluation of several diseases including chronic renal failure, hypoparathyroidism, sarcoidosis, and rickets. Measurement of 1α,25-dihydroxyvitamin D is very challenging due to its low circulating concentration and presence of interfering substances in serum. In this report, a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for quantifying serum 1α,25-dihydroxyvitamin D is described. Lithium adducts of 1α,25-dihydroxyvitamin D were formed prior to mass spectrometry analysis to improve ionization efficiency. We tested a number of different sample preparation procedures and found that immunoaffinity extraction was the method of choice because it completely removed isobaric interferences and matrix effects present in patient serum. Extraction efficiency, expressed as absolute recovery, was greater than 60% in both patient serum and charcoal-stripped serum. This method was linear from 3.4 to 206.2 pg/mL for 1α,25-dihydroxyvitamin D(3) and 3.9 to 212.6 pg/mL for 1α,25-dihydroxyvitamin D(2) with an accuracy of 89.8-98.4% and 97.5-115.7%, respectively. Inter-assay and intra-assay coefficients of variance (CVs) for both analytes at two different concentration levels ranged from 2.5-7.0%. Comparison with a radioimmunoassay for measuring total 1α,25-dihydroxyvitamin D concentration using 40 patient samples showed a Deming regression slope of 0.751, a y-intercept of 0.84 pg/mL, an r value of 0.7909, and a mean percentage difference of -27.1%. Comparison with a reference LC/MS/MS method (n = 20) showed a Deming regression slope of 1.020, a y-intercept of 1.32 pg/mL, an r value of 0.9797, and a mean percentage difference of -2.9%. In conclusion, usage of immunoaffinity extraction enabled a sensitive LC/MS/MS method for quantification of 1α,25-dihydroxyvitamin D in serum.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488122     DOI: 10.1002/rcm.4988

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  10 in total

1.  A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine.

Authors:  Debin Wan; Jun Yang; Bogdan Barnych; Sung Hee Hwang; Kin Sing Stephen Lee; Yongliang Cui; Jun Niu; Mitchell A Watsky; Bruce D Hammock
Journal:  J Lipid Res       Date:  2017-02-01       Impact factor: 5.922

Review 2.  Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.

Authors:  Christoph Seger
Journal:  Wien Med Wochenschr       Date:  2012-11-06

3.  Lithium ion adduction enables UPLC-MS/MS-based analysis of multi-class 3-hydroxyl group-containing keto-steroids.

Authors:  Qiuyi Wang; Kimiko Shimizu; Kanako Maehata; Yue Pan; Koki Sakurai; Takatoshi Hikida; Yoshitaka Fukada; Toshifumi Takao
Journal:  J Lipid Res       Date:  2020-02-26       Impact factor: 5.922

4.  Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.

Authors:  Zhican Wang; Tauri Senn; Tom Kalhorn; Xi Emily Zheng; Songmao Zheng; Connie L Davis; Mary F Hebert; Yvonne S Lin; Kenneth E Thummel
Journal:  Anal Biochem       Date:  2011-07-13       Impact factor: 3.365

5.  Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.

Authors:  A Zittermann; M Morshuis; J Kuhn; S Pilz; J B Ernst; C Oezpeker; J Dreier; C Knabbe; J F Gummert; H Milting
Journal:  Eur J Nutr       Date:  2015-02-06       Impact factor: 5.614

Review 6.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

7.  Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 Dihydroxyvitamin D2&3 measurement using a novel derivatization agent.

Authors:  Curtis J Hedman; Donald A Wiebe; Subhakar Dey; Josh Plath; Joseph W Kemnitz; Toni E Ziegler
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-02-04       Impact factor: 3.205

8.  Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry.

Authors:  Thomas J Laha; Frederick G Strathmann; Zhican Wang; Ian H de Boer; Kenneth E Thummel; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2012-09-11       Impact factor: 8.327

Review 9.  The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine.

Authors:  Niek F Dirks; Mariëtte T Ackermans; Paul Lips; Renate T de Jongh; Marc G Vervloet; Robert de Jonge; Annemieke C Heijboer
Journal:  Nutrients       Date:  2018-04-13       Impact factor: 5.717

10.  Measurement of Circulating 1,25-Dihydroxyvitamin D: Comparison of an Automated Method with a Liquid Chromatography Tandem Mass Spectrometry Method.

Authors:  Armin Zittermann; Jana B Ernst; Tobias Becker; Jens Dreier; Cornelius Knabbe; Jan F Gummert; Joachim Kuhn
Journal:  Int J Anal Chem       Date:  2016-04-05       Impact factor: 1.885

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.